eli lilly tirzepatide patent expiration Sandoz files first generic ANDAs ahead of Lilly's cliff Looming GLP-1 drug patent expirations

The SLEP findings about conventional drugs do not apply to peptide therapeutics, and anyone telling you otherwise is dangerously oversimplifying the science

Thus far, the effect of tirzepatide on cardiovascular risk factors has indicated improvements in lipids, lipoprotein profiles, glucose control, body weight, blood pressure, and several biomarkers of inflammation in adults with overweight or obesity both with and without T2D (Tables 1, 2, 3, 4)

Healthcare providers should educate patients on these requirements during initial prescribing and reinforce them at follow-up visits, particularly for patients new to injectable therapies

The medication prolongs feelings of fullness, making it easier to stick to nutritional plans and maintain weight loss

Your appetite wont be reduced as much as it was when you were on the medications, but some evidence-based strategies can reduce it

[1] Liraglutide isnt recommended for people with a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) or a rare condition called Multiple Endocrine Neoplasia syndrome type 2